APLS Q4 2017 Earnings — Apellis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

APLSApellis Pharmaceuticals, Inc.

$2B

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$11,542

Gross Profit

$11,542100.0% margin

Operating Income

-$18M-155891.5% margin

Net Income

-$18M-158170.2% margin

EPS (Diluted)

$-0.53

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$16M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$182M

Total Liabilities

$33M

Stockholders' Equity

$149M

Cash & Equivalents

$176M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11,542	$0	—
Gross Profit	$11,542	$0	—
Operating Income	-$18M	-$7M	-169.4%
Net Income	-$18M	-$7M	-175.8%